Peptide Therapeutics vor Fusion - 500 Beiträge pro Seite

[thunder]

Heute um 25 % gestiegen.


Two rivals eye biotech firm Peptide -FT


LONDON (Reuters) - Biotechnology firm Peptide Therapeutics (LSE: PTE.L - news) Group, which specialises in vaccines, has received informal approaches from at least two UK-based competitors, the Financial Times said.

The paper quoted industry observers saying they believed Cantab Pharmaceuticals Plc (LSE: CTB.L - news) -- which has a strong presence in vaccines -- had opened talks which could lead to a bid or a merger.

Drug delivery specialist Powderject Pharmaceuticals Plc (LSE: PJP.L - news) was also said to be interested in using Peptide`s vaccines in its needleless injection system.

The newspaper said the talks were at a very early stage.

It added that Oxford Biomedica Plc (LSE: OXB.L - news) was understood to have held informal discussions in the past but was not believed to be in talks at present.

Peptide has several drugs in trials but is seen as lacking critical mass. The company was valued at 79 million pounds at Wednesday`s close, after reporting positive results from Phase I trials of an oral vaccine against travellers` diarrhoea.




--------------------------------------------------------------------------------
More Quotes and News: Cantab Pharmaceuticals PLC (London: CTB.L, News, Profile, Research)
Oxford BioMedica PLC (London: OXB.L, News, Profile, Research)
PowderJect Pharmaceuticals PLC (London: PJP.L, News, Profile, Research)
Peptide Therapeutics PLC (London: PTE.L, News, Profile, Research)

Habe diese aktie in diesem Board schon länger empfohlen und jetzt heisst es erst recht kaufen oder dazukaufen.

wurden gestern auf strong buy gesetzt.

grus thunder

[virus]

Hey thunder

jetzt wird es abgehen. Sind heute wieder im Plus und das nachdem gestern Nasdaq stark korrigiert hat.

es sind 2 Firmen an der übernahme von Peptide Therapeutics interessiert. Das wird den Preis noch stark nach oben jagen.

Diese aktie hat sehr hohe kurschancen.

gruss Virus.